US Patent Issued to Hummingbird Bioscience on June 2 for "BCMA/TACI antigen-binding molecules" (Singaporean Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,952, issued on June 2, was assigned to Hummingbird Bioscience Pte. Ltd. (Singapore).

"BCMA/TACI antigen-binding molecules" was invented by Fabien Decaillot (Singapore), Jerome Douglas Boyd-Kirkup (Singapore), Dipti Thakkar (Singapore), Piers Ingram (Singapore), Konrad Paszkiewicz (Singapore) and Chia-Yi Liu (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "BCMA/TACI antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the BCMA/TACI antigen-binding molecules."

The patent was filed on Nov. 2, 2021, under Application No. 18/034,867.

*For further i...